NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds Biotech Health services Pharma Investments 01 September 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 67.25M Round investors: SV Health InvestorsMerck VenturesNovartis Venture FundCaixa Capital RiscBrandon Capital PartnersOmega FundsBritish Business Bank Company: NRG Therapeutics Industry: BiotechHealth servicesPharma
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden. Health services Pharma Investments 02 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus Biotech Health services Manufacturing Pharma Software Services Investments 01 October 2025
Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA AI (big data) Biotech Health services Software Services Investments 02 August 2025
Juvenescence raised $76m in a first close of its Series B1 round led by M42. Biotech Health services Manufacturing Pharma Investments 10 May 2025